Corvus Pharmaceuticals
CRVS
CRVS
92 hedge funds and large institutions have $167M invested in Corvus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 87 → 92 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
30% less call options, than puts
Call options by funds: $702K | Put options by funds: $1.01M
Holders
92
Holding in Top 10
2
Calls
$702K
Puts
$1.01M
Top Buyers
| 1 | +$17M | |
| 2 | +$12.7M | |
| 3 | +$5.75M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.15M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.09M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$5.21M | |
| 3 | -$3.53M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.62M |
| 5 |
Jane Street
New York
|
-$991K |
